JPWO2021020564A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021020564A5 JPWO2021020564A5 JP2021535464A JP2021535464A JPWO2021020564A5 JP WO2021020564 A5 JPWO2021020564 A5 JP WO2021020564A5 JP 2021535464 A JP2021535464 A JP 2021535464A JP 2021535464 A JP2021535464 A JP 2021535464A JP WO2021020564 A5 JPWO2021020564 A5 JP WO2021020564A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen receptor
- chimeric antigen
- ganglioside
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019142358 | 2019-08-01 | ||
| JP2019142358 | 2019-08-01 | ||
| PCT/JP2020/029446 WO2021020564A1 (ja) | 2019-08-01 | 2020-07-31 | Gd2結合性分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021020564A1 JPWO2021020564A1 (cg-RX-API-DMAC7.html) | 2021-02-04 |
| JPWO2021020564A5 true JPWO2021020564A5 (cg-RX-API-DMAC7.html) | 2022-06-01 |
| JP7505784B2 JP7505784B2 (ja) | 2024-06-25 |
Family
ID=74228907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021535464A Active JP7505784B2 (ja) | 2019-08-01 | 2020-07-31 | Gd2結合性分子 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220275104A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4008347B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7505784B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022001649A2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3031393T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021020564A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7521815B2 (ja) * | 2019-08-01 | 2024-07-24 | 国立大学法人三重大学 | 抗原受容体 |
| WO2023081485A1 (en) | 2021-11-08 | 2023-05-11 | Pacific Biosciences Of California, Inc. | Stepwise sequencing of a polynucleotide with a homogenous reaction mixture |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5654986B2 (ja) * | 2008-06-30 | 2015-01-14 | モーフオテク・インコーポレーテツド | 抗gd2抗体並びにそれに関連する方法及び使用 |
| NZ603581A (en) * | 2010-06-19 | 2015-05-29 | Sloan Kettering Inst Cancer | Anti-gd2 antibodies |
| EP2614143B1 (en) * | 2010-09-08 | 2018-11-07 | Baylor College Of Medicine | Immunotherapy of non-small lung cancer using genetically engineered gd2-specific t cells |
| WO2013189516A1 (en) * | 2012-06-18 | 2013-12-27 | Apeiron Biologics Ag | Method for treating a gd2 positive cancer |
| GB201403972D0 (en) * | 2014-03-06 | 2014-04-23 | Ucl Business Plc | Chimeric antigen receptor |
| US11248058B2 (en) * | 2015-02-19 | 2022-02-15 | University Of Florida Research Foundation, Inc. | Chimeric antigen receptors and uses thereof |
| KR20230100748A (ko) * | 2016-07-28 | 2023-07-05 | 노파르티스 아게 | 키메라 항원 수용체 및 pd-1 억제제의 조합 요법 |
| EP3600357A4 (en) * | 2017-03-31 | 2021-01-06 | The Board of Trustees of the Leland Stanford Junior University | METHODS OF TREATING T-LYMPHOCYTE DEPLETION BY INHIBITING OR MODULATING T-LYMPHOCYTE RECEPTOR SIGNALING |
| CN118853581A (zh) * | 2017-06-21 | 2024-10-29 | 美商生物细胞基因治疗有限公司 | 嵌合抗原受体(CARs)、组合物及其使用方法 |
| IT201800007601A1 (it) * | 2018-07-30 | 2020-01-30 | Rigenerand Srl | Metodo per la produzione di cellule bi-funzionali per il trattamento di tumori |
| IL288807B1 (en) * | 2019-06-13 | 2026-08-01 | Allogene Therapeutics Inc | ANTI-TALEN ANTIBODIES AND THEIR USES |
-
2020
- 2020-07-31 EP EP20845660.8A patent/EP4008347B1/en active Active
- 2020-07-31 ES ES20845660T patent/ES3031393T3/es active Active
- 2020-07-31 WO PCT/JP2020/029446 patent/WO2021020564A1/ja not_active Ceased
- 2020-07-31 US US17/631,745 patent/US20220275104A1/en active Pending
- 2020-07-31 BR BR112022001649A patent/BR112022001649A2/pt unknown
- 2020-07-31 JP JP2021535464A patent/JP7505784B2/ja active Active